Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Katherine Stamp
Introduction
Katherine Stamp is a notable inventor based in Montclair, NJ (US). She has made significant contributions to the field of biomedical research, particularly in the area of drug development. Her work focuses on methods for screening compounds that modify cereblon, a protein involved in various diseases.
Latest Patents
Katherine holds a patent for "Methods for screening cereblon modifying compounds." This patent describes a method of screening a cereblon modifying compound for treating a disease or disorder. The process involves obtaining a sample, determining the first protein level of SALL, administering the cereblon modifying compound to the sample, determining the second protein level of SALL, and comparing the two levels to assess whether the compound induces degradation of SALL. The goal is to select a cereblon modifying compound that does not induce degradation of SALL.
Career Highlights
Katherine is currently employed at Celgene Corporation, where she continues to advance her research in drug development. Her innovative approach has the potential to lead to new treatments for various diseases, showcasing her commitment to improving healthcare outcomes.
Collaborations
Katherine has collaborated with esteemed colleagues, including Mary Matyskiela and Philip Chamberlain. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in the field.
Conclusion
Katherine Stamp's work exemplifies the impact of innovative research in the biomedical field. Her patent and ongoing contributions at Celgene Corporation highlight her dedication to developing effective treatments for diseases.